CARDIOSTER
Sources: the KBO register on 21-11-2026; the National Bank, 2025 annual accounts filed on 18-06-2026; the Belgian Official Gazette, latest deed of 27-02-2024.
Grounds
the facts the verdict rests on, each with its source- CARDIOSTER made a profit in every financial year since 2009. The profit of 2025, €257,753, is the highest so far.Annual accounts 2009 to 2025 page 2
- Equity stands at €583,286, or 79.9% of the balance sheet total of €730,327. The solvency of 79.9% is higher than at 80% of the 10,299 companies filing micro accounts in office administrative support (NACE 82) in 2025.Annual accounts 2025 page 2
- CARDIOSTER paid out €100,000 in dividends, 39% of the profit of 2025.Annual accounts 2025 page 2
- Cash rose from €440,923 to €578,233. Debts due within one year fell from €165,689 to €147,042.Annual accounts 2024 and 2025 page 2
- The last five annual accounts came in on time. The 2025 accounts were filed 43 days before the end of the term.National Bank, filing of 18-06-2026 page 4
Representation
The articles of association in the Belgian Official Gazette set who represents CARDIOSTER.
Ownership
The accounts in the micro format list no shareholders. holds 372 shares.
Deed of 10-01-2014
Financial situation
Annual accounts 2021 to 2025, as filed with the National Bank
Gross margin and net resultin euro
Equity and debtsin euro
Cashin euro
| Financial year | 2021 | 2022 | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|---|---|
| Results | ||||||
| Gross margin | €213,536 | €229,371 | €280,189 | €334,308 | €374,502 | |
| Operating result | €199,636 | €226,049 | €276,920 | €319,560 | €359,957 | |
| Net result | €150,671 | €171,904 | €200,545 | €231,144 | €257,753 | |
| Balance sheet at the closing date | ||||||
| Equity | €196,398 | €193,844 | €294,389 | €425,533 | €583,286 | |
| Debts | €329,658 | €339,276 | €143,937 | €165,689 | €147,042 | |
| Debts due within one year | €329,658 | €339,276 | €143,937 | €165,689 | €147,042 | |
| Cash | €436,310 | €457,463 | €344,750 | €440,923 | €578,233 | |
| Balance sheet total | €526,056 | €533,120 | €438,326 | €591,222 | €730,327 | |
| Ratios | ||||||
| Solvency | 37.3% | 36.4% | 67.2% | 72.0% | 79.9% | |
| Liquidity | 1.58 | 1.56 | 2.96 | 3.24 | 4.68 | |
Source: Annual accounts 2025, micro format, filed on 18-06-2026 (2026-00171109); Annual accounts 2024, micro format, filed on 06-06-2025 (2025-00123595); Annual accounts 2021 to 2023, filed from 15-07-2022 to 29-05-2024 (2022-20189322, 2023-00186122, 2024-00099577).
The operating result of 2025 is 13% higher than in 2024 and the highest since 2009.
Debts fell by €18,647 in 2025.
The 2025 annual accounts state no amount of overdue tax or social security (RSZ) debts.
CARDIOSTER states no turnover; the micro format does not require it. The gross margin, what is left after purchases, rose from €334,308 to €374,502.
Board, signature and ownership
Position on 21-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts
Who represents the company
The articles of association in the Belgian Official Gazette set who represents CARDIOSTER.
Board
one director in officeOwnership and group
Shareholders
The accounts in the micro format list no shareholders. holds 372 shares.
Deed of 10-01-2014
Board changes
changes role from manager to director. Discharge granted to . General meeting of 22-12-2022.
Gazette, deed 22387255Events and comparison
The last 24 months, newest first
Annual accounts 2025 filed, 43 days before the deadline.
NBB filingHighest result from 2009 to 2025. The operating result of €359,957 and the net result of €257,753 are both a record.
FinancialEquity above €500,000. Equity rises from €425,533 to €583,286.
FinancialAnnual accounts 2024 filed, 55 days before the deadline.
NBB filingComparable companies, two years later
In July 2024, 17,817 companies had the same profile as CARDIOSTER has now: small, 10 to 20 years old, solvency 30% or more and a profit of 5% of the balance sheet or more. Two years later 96.5% were still trading, 3.2% had stopped another way and 0.3% had gone bankrupt.
The return on assets of CARDIOSTER, 35.3%, is higher than at 80% of the 10,021 companies filing micro accounts in office administrative support (NACE 82) in 2025.
Other findings
Peppol
Reachable for e-invoices since 20-11-2020, under 0208:0809715418.
Sanctions lists
Sources and method
Where each fact in this report comes from
| Source | What | Date | Reference |
|---|---|---|---|
| KBO register | Registration, legal situation, activity, establishment units | 21-11-2026 | KBO 0809.715.418 |
| National Bank of Belgium | Annual accounts 2025, micro format | 18-06-2026 | 2026-00171109 |
| National Bank of Belgium | Annual accounts 2024, micro format | 06-06-2025 | 2025-00123595 |
| National Bank of Belgium | Annual accounts 2021 to 2023 | 15-07-2022 to 29-05-2024 | 2022-20189322, 2023-00186122, 2024-00099577 |
| Belgian Official Gazette | Board | 27-12-2022 | deed 22387255 |
| Peppol Directory | Registration for e-invoices | 20-11-2020 | 0208:0809715418 |
| Sanctions lists EU, UN, US (OFAC) and UK | Comparison of the name | 19-11-2026 | |
| Checked | Checked score, bankruptcy probability, credit, comparable companies | 20-11-2026 | bankruptcy model of 2 October 2026 |
Method
Checked score. A number from 0 to 100. The bankruptcy probability sets the class, from Critical to Excellent; within the class, the comparison with sector peers on solvency, liquidity, profitability and growth counts for half.
Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 2 October 2026, computed on 20-11-2026.
Credit. The credit is a tenth of equity, weighted by the score, and never more than a tenth of turnover. With negative equity there is no credit.
Comparable companies. Companies of the same size, age, solvency and profitability at an earlier date, followed two years later in the KBO register and the Gazette.
The scores and ratios are Checked's own calculations, not a credit decision.